Biotronik has announced that the first US patient has been implanted with the company’s Eluna pacemaker system with ProMRI technology. The Eluna pacing system allows patients to undergo full-body magnetic resonance imaging (MRI) scans.
Until recently, patients with a pacemaker or implantable cardioverter defibrillator (ICD) were denied access to MRI due to concerns that the strong magnetic fields and radio waves created by an MRI scanner could have a negative effect on both the implanted device and the patient. With its ProMRI technology, Biotronik has developed a solution that will grant all cardiac rhythm patients access to vital MRI scans.
“As a physician, this is the kind of care I want to deliver to my patients,” says Nicholas Skipitaris, electrophysiologist at Lenox Hill Hospital, New York, USA. “Patients and hospitals can be confident in the safety of MR conditional technology, which has passed Food and Drug Administration (FDA) approval. These devices will become standard of care in my practice.”
In addition to Lenox Hill Hospital, other facilities already implanting the Eluna ProMRI pacing system include:
- NYU Medical Center, New York
- University of Massachusetts Memorial Medical Center, Worcester
- New York Presbyterian, New York
- Massachusetts General Hospital, Boston
- Community Heart and Vascular, Indianapolis
- Scripps Mercy Hospital, San Diego
- Orlando Regional Medical Center, Orlando
- Saddleback Memorial Medical Center, Laguna Hills
- Sharp Grossmont Hospital, La Mesa
Eluna devices include wandless radio frequency (RF) telemetry for efficient device programming and interrogation at implant, the most physiologic therapy available via Closed Loop Stimulation (CLS), and HF Monitor and thoracic impedance (TI) diagnostics to provide vital information on heart failure progression.